April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 14, 2026
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 7.49 billion in 2025, is anticipated to reach USD 17.57 billion by 2035, growing at a CAGR of 8.9% over the next decade. In 2023, medications led the Parkinson’s disease market with a 40% share, while North America dominated at ...
January 14, 2026
Projections indicate that, the global anxiety disorders treatment market will increase from USD 12.33 billion in 2025 to USD 17.56 billion by 2035, experiencing a CAGR of 3.6% over the next 10 years. Anxiety disorder treatment helps manage excessive worry and fear through therapy, medication, or lifestyle changes. Common options include cognitive b...
January 14, 2026
Based on market forecasts, the chronic obstructive pulmonary disease sector will expand from USD 23.55 billion in 2025 to USD 36.29 billion by 2035, experiencing a CAGR of 4.42%. In 2023, North America led the COPD market, with chronic bronchitis and drug treatments taking the top spots. Hospitals and clinics were the key end users. Looking ahead, ...
January 14, 2026
Based on our forecasts, the behavioural mental health tools market was valued at USD 3.36 billion in 2025 and is expected to grow from USD 3.85 billion in 2026 to USD 13.28 billion by 2035, registering a CAGR of 14.74% during the forecast period....
January 13, 2026
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 19.55 billion in 2025 to USD 30.65 billion by 2035, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage by controlling the immune system’s overactive response. Treatments include NSAIDs for pain, ste...
January 12, 2026
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as there's no cure yet. Medications help control movement issues and mood changes, while therapy suppor...
January 09, 2026
Market insights predict, the antibodies drug industry is expected to grow from USD 272.3 billion in 2025 to USD 759.36 billion by 2035, driven by a CAGR of 10.8%. The increase in the production of monoclonal antibodies is leading to higher demand for the antibodies drugs....
January 09, 2026
Based on market forecasts, the global plastic surgery market, projected at USD 85.98 billion in 2025, is expected to reach USD 245.46 billion by 2035, growing at a CAGR of 11.06% over the forecast period.The market is growing due to rising demand for aesthetic enhancement and increasing acceptance of cosmetic procedures across all age groups. Techn...
January 09, 2026
Based on our market forecasts, the dermatology and plastic surgery sector will expand from USD 42.96 billion in 2025 to USD 101.69 billion by 2035, experiencing a CAGR of 9%. The rising prevalence of skin disorders and the need for aesthetic appearance drive the global market. North America dominated the market owing to the presence of a robust hea...
January 09, 2026
According to our research, the mental health medications market was valued at USD 24.25 billion in 2025 and is projected to grow from USD 25.76 billion in 2026 to USD 44.26 billion by 2035, registering a CAGR of 6.2% during 2026 to 2035....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com